Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process
Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.
EP: 1.Navigating T1D: Mitigating Burden and Monitoring Disease Progression
EP: 2.T1D Staging: The Clinical Importance of Early Recognition
EP: 3.Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care
EP: 4.T1D Antibody Screening: Identifying High-Risk Populations
EP: 5.Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression
EP: 6.TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data
EP: 7.Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
EP: 8.Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview
Now Viewing
EP: 9.Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process
EP: 10.Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab
Related Videos
